Company Name: Hemispherx BioPharma, Inc
Code: AMEX:HEB publicly traded American Stock Exchange "USA
Risk: High
Rating: Buy

The Hemispherx BioPharma is a relatively small pharmaceutical company that already has to his credit, however, some pharmaceutical patents (Alferon N Injection).

The studies focused on the drug Ampligen have been successful on the treatment of different influences appeared in recent years.

If the studies are confirmed and approved medication gain of this initiative will be significant given the low prices of the
current period.

At the news medium has strong positive action increases.